Company Filing History:
Years Active: 2024
Title: Kimberly Jayne Gaspar: Innovator in Pharmaceutical Compositions
Introduction
Kimberly Jayne Gaspar is a notable inventor based in Saskatoon, Canada. She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative therapeutic compositions. Her work focuses on antibody-urease conjugates, which have promising applications in cancer treatment.
Latest Patents
Kimberly holds 1 patent for her invention titled "Antibody-urease conjugates for therapeutic purposes." This patent describes pharmaceutical compositions that comprise antibody-urease conjugates and are substantially free of unconjugated urease. The compositions are prepared using a method that does not require chromatographic purification. These pharmaceutical compositions are designed for use in cancer treatment through antibody-directed enzyme prodrug therapy, where urease converts endogenous urea into ammonia in situ to induce cytotoxicity.
Career Highlights
Kimberly is currently associated with Helix Biopharma Corporation, where she continues to advance her research and development efforts. Her innovative approach to pharmaceutical compositions has positioned her as a key player in the industry.
Collaborations
Some of her notable coworkers include Heman Chao and Wah Yau Wong, who contribute to her research endeavors and collaborative projects.
Conclusion
Kimberly Jayne Gaspar's work in developing antibody-urease conjugates represents a significant advancement in therapeutic applications for cancer treatment. Her contributions to the field of pharmaceuticals highlight the importance of innovation in addressing complex medical challenges.